Fragmin/protamine microparticle-coated matrix immobilized cytokines to stimulate various cell proliferations with low serum media

Artificial Organs

Volumn 33, Issue 6, 2009, Pages 431-438

  Kishimoto, Satoko ^a,b   Nakamura, Shingo ^a   Nakamura, Shin Ichiro ^a   Kanatani, Yasuhiro ^a   Hattori, Hidemi ^a   Tanaka, Yoshihiro ^a   Harada, Yasuji ^b   Tagawa, Masahiro ^b   Mori, Yasutaka ^a   Maehara, Tadaaki ^a   Ishihara, Masayuki ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

Author keywords

Cytokines; Heparin binding growth factors; Low serum media; Matrix; Nanoparticles

Indexed keywords

BODY FLUIDS; CELL PROLIFERATION; ENDOTHELIAL CELLS; FIBROBLASTS; POLYSACCHARIDES;

CYTOKINES; FETAL BOVINE SERUM; FIBROBLAST CELLS; HEPARIN BINDING; HEPARIN BINDING GROWTH FACTORS; HUMAN DERMAL FIBROBLASTS; HUMAN MICROVASCULAR ENDOTHELIAL CELLS; LOW SERUM MEDIUM; MATRIX; MICRO PARTICLES;

CELL CULTURE;

DALTEPARIN; FIBROBLAST GROWTH FACTOR 2; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; NANOPARTICLE; PROTAMINE;

ARTICLE; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CELL STIMULATION; CULTURE MEDIUM; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MATERIAL COATING; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION;

BOVINAE;

EID: 66449100677     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2009.00745.x     Document Type: Article

References (20)

1. Jackson RL, Busch SJ, Cardin AD. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev 1991 71 : 481 539.
2. Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 1991 64 : 867 9.
3. Ishihara M, Ono K. Structure and function of heparin and heparan sulfate; heparinoid library and modification of FGF-activities. Trends Glycosci Glycotechnol 1998 10 : 223 33.
4. Rapraeger AC, Krufka A, Olwin BB. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 1991 252 : 1705 8.
5. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991 64 : 841 8.
6. Spivak-Kroizman T, Leommon MA, Dikic I, et al. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 1994 79 : 1015 24.
7. Ishihara M. Biosynthesis, structure, and biological activity of basic FGF binding domains of heparan sulfate. Trends Glycosci Glycotechnol 1993 5 : 343 54.
8. Salmivirta M, Lidholt K, Lindahl U. Heparan sulfate: a piece of information. FASEB J 1996 10 : 1270 9.
9. Lindahl U, Lidholt K, Spillmann D, Kjellen L. More to "heparin" than anti coagulation. Thromb Res 1994 75 : 1 32.
10. Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular-weight heparin. Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001 119 : 64S 94S. (Pubitemid 32154195)
11. R) at the site of activation of the coagulation system in man. J Thromb Haemost 1995 73 : 439 43.
12. Pan M, Lezo JS, Medina A, et al. In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation. Am J Cardiol 1997 80 : 1336 8.
13. Nakamura S, Kanatani Y, Kishimoto S, et al. Controlled release of FGF-2 using fragmin/protamine microparticles and effect on neovascularization. J Biomed Mater Res (A) 2008 Dec 2. [Epub ahead of print]
14. Kitamura T, Tojo A, Kuwaki T, et al. Identification and analysis of human erythropoietin receptors on a factor-dependent cell line, TF-1. Blood 1989 73 : 375 80.
15. Kitamura T, Takaku F, Miyajima A. IL-1 up-regulates the expression of cytokine receptors on a factor-dependent human hemopoietic cell line, TF-1. Int Immunol 1991 3 : 571 7.
16. Nakamura S, Nambu M, Kishimoto S, et al. Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex hydrogel on in vitro and in vivo vascularization. J Biomed. Mater. Res (A) 2008 85A : 619 27.
17. Fujita M, Ishihara M, Shimizu M, et al. Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel. Biomaterials 2004 25 : 699 706. (Pubitemid 37357283)
18. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997 276 : 71 4.
19. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999 284 : 143 7.
20. Spees JL, Gregory CA, Singh H, et al. Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 2004 9 : 747 56.